Joseph Drabick

Joseph Drabick, MD is a Professor and Rose Dunlap Division Chief Chair in Hematology/Oncology at the Penn State Cancer Institute, Department of Medicine. His work focuses on clinical research in hematologic malignancies, cancer therapy, and drug resistance mechanisms.

• Primary Affiliation: Penn State Cancer Institute
• Division: Hematology and Oncology
• Research Themes: Cancer treatment, immunotherapy, tumor heterogeneity

Research Interests: Active in oncology, including metastatic melanoma, radiation therapy, and clinical trials. His contributions also span health promotion through phytochemicals and in vivo molecular targeting.

Recent Articles highlight advancements in mantle cell lymphoma therapy, checkpoint inhibition, and molecular dynamics in drug-treated tumors, reflecting his focus on translational science and clinical applications.

• Awards: Fellow, American College of Physicians (FACP)

Collaborations include multidisciplinary teams in academia and clinical settings, contributing to UN Sustainable Development Goals via cancer research and global health initiatives.